Communicable Diseases CEN Study Guide

Communicable Diseases CEN Study Guide

CEN Study Guide covers a wide range of nursing specialties, including obstetrics, geriatrics, community health, and psychiatric nursing.

Communicable Diseases CEN Study Guide

Clostridium difficile (C. Difficile)

Pathophysiology

Clostridium difficile (commonly called C. diff) is an acute bacterial infection in the intestine most commonly seen after antibiotic use. The antibiotics disrupt the normal intestinal flora, allowing; the antibiotic-resistant C. diff spores to proliferate in the intestines. The bacterium releases a toxin that causes the intestine to produce yellow-white plaques on the intestinal lining. The C. diff infection can produce inflammation in the intestines, resulting in toxic colitis (toxic megacolon) or pseudomembranous colitis, and may also lead to perforation and sepsis.

Transmission and Precautions    

  • Fecal to oral transmission
  • Use contact precautions
  • Do not use foams and gels (they will not kill the spores)
  • Environmental cleanse of a 1:10 bleach-to-water solution

Physical Examination        

  • Foul-smelling diarrhea 5-10 days after start of antibiotic.
  • Signs and symptoms of toxic colitis: tenesmus, rectal bleeding, abdominal distension and tenderness.

Diagnostic Tests

  • Enzyme immunoassay (EIA): most commonly run diagnostic test
  • PCR test on the stool specimen: most sensitive and specific diagnostic test

Management            

Antibiotic-induced C. diff: stop current use of antibiotics if possible 

Oral antibiotics; IV if oral antibiotics cannot be tolerated

  • Vancomycin (Vancocin)
  • Fidaxomicin (Dificid)
  • Metronidazole (Flagyl)

Vaccine-Preventable Diseases

CHICKENPOX

Pathophysiology

Chicken pox (varicella-zoster virus) is a viral infection that infects the conjunctiva or the mucous membranes of the upper respiratory tract. The infection then spreads, causing the hallmark rash of small, itchy, fluid-filled blisters all over the body.

Transmissions and Precautions

  • Person to person through direct contact or airborne droplets
  • Airborne, droplet, and contact precautions

Physical Examination

  • Itchy rash that forms small fluid-filled blisters that eventually scab
  • Mild headache
  • Moderate fever
  • Fatigue 

Diagnostic Tests

  • Varicella titer test on a blood sample
  • Tzanck test performed on a swab sample of the lesion area

Management    

  • Supportive care for symptoms (systemic antihistamines, colloidal oatmeal baths)
  • Antivirals in severe cases

DIPHTHERIA

Pathophysiology

Diphtheria is an infection caused by the bacterium Corynebacterium diphtheriae. The bacterium enters through the pharynx or the skin and releases a toxin that causes inflammation and necrosis.

Transmissions and Precautions

  • Person to person through respiratory droplets (pharyngeal infection)
  • Person to person skin contact (skin infection)
  • Droplet, contact precautions

Physical Examination

  1. White or gray glossy exudate in the back of the throat
  2. Mild sore throat and hoarseness
  3. Serosanguinous or purulent discharge
  4. Difficulty swallowing or getting food stuck in throat
  5. Visibly swollen neck (bull neck)
  6. Stridor 
  7. Low-grade fever
  8. Skin infection: non-specific symptoms

Diagnostic Tests

positive culture from swab

Management

  • Diphtheria antitoxin (IM or IV)
  • Antibiotics (penicillin, erythromycin)
  • Clean skin infection with soap and water
  • Diphtheria vaccination after recovery

MEASLES

Pathophysiology

Measles is an acute, highly contagious infection caused by a paramyxovirus. The virus enters through the upper respiratory tract or conjunctiva and spreads systemically through the lymph nodes, triggering a systemic inflammatory response. Infants, elderly patients, and immunocompromised patients are more likely to experience serious complications such as pneumonia and encephalitis.

Transmissions and Precautions

  • Person to person through respiratory droplets that can live in the air or on hard surfaces for up to 2 hours
  • Airborne, droplet, and contact precautions

Physical Examination

  1. Fever
  2. Cough
  3. Runny nose and conjunctivitis
  4. Sore throat
  5. Koplik spots
  6. Red, blotchy rash (usually starts on the face and spreads cephatocaudally)

Communicable Diseases CEN Study Guide 1

Figure: Koplik spots

Diagnostic Tests

Positive PCR or serum measles IgM antibody

Management

  • Vitamin A
  • Antivirals (ribavirin) for high-risk patients
  • Supportive care for symptoms
  • Prophylaxis for high-risk contacts (MMR vaccine or immune globulin)

MUMPS

Pathophysiology 

Mumps is an acute infection caused by a paramyxovirus. The virus causes an inflammatory response that results in swelling of the salivary glands (usually the parotid glands). Possible complications include epididymo-orchitis, meningitis, encephalitis, and hearing loss.

Transmissions and Precautions

  • Person to person through respiratory droplets in close proximity
  • Droplet precautions

Physical Examination

  1. Fever
  2. Salivary gland edema
  3. Parotitis
  4. Pain when chewing or swallowing
  5. Swelling in submandibular glands or tongue

Diagnostic Tests    

Positive serum IgM or PCR

Management

Supportive care for symptoms (acetaminophen, warm/cold packs for swelling)

PERTUSSIS

Pathophysiology

Pertussis (whooping cough) is an infection caused by the bacterium Bordetella pertussis that causes a mucopurulent sanguineous exudate that can compromise the respiratory tract.

Transmissions and Precautions 

  • Person to person through respiratory droplets in close proximity
  • Droplet precautions

Physical Examination    

Paroxysmal or spasmodic cough (“whoop”) that ends in a prolonged, high-pitched inspiration

Diagnostic Tests     

PCR on nasal or throat swab

Management    

  • Antibiotics (erythromycin, azithromycin)
  • Supportive, care for symptoms, including suctioning

Influenza

Pathophysiology

Influenza (flu) is a group of contagious viruses that cause respiratory symptoms and fever. Four types of human influenza viruses have been identified (A, B, C, and D); only types A and B cause severe illness in people. Flu is a common seasonal illness that tends to be more widespread during the fall and winter. However, infection may occur at any time of the year.

Symptoms of flu typically appear suddenly and can range from mild to life-threatening. For most people, flu is a self-limiting infection that does not require emergent care. High-risk patients may develop severe complications, including pneumonia, sepsis, myositis, seizure, and encephalopathy. 

Risk factors for severe flu complications include:

  1. Age of < 2 years or > 65 years
  2. Being immunocompromised
  3. Pregnancy
  4. Asthma or chronic lung disease
  5. Diabetes
  6. Obesity
  7. Heart, liver, kidney, or metabolic disorders

Transmissions and Precautions    

  • Transmission through mucous membrane contact and respiratory droplets
  • Contact and droplet precautions

Physical Examination

  1. Fever
  2. Headache
  3. Myalgia
  4. Nonproductive cough
  5. Sore throat
  6. Nausea and vomiting

Diagnostic Tests

Rapid influenza diagnostic test or molecular assay (more reliable)

Management

Pharmacological management of symptoms

  • Antipyretics    
  • Cough suppressant
  • Antiemetics
  1. Antiviral drugs administered to high-risk patients and patients with symptom onset of < 48 hours previous
  2. Monitor for and manage complications
  3. Isolate until symptoms resolve or at least 24 hours after fever has gone

Drug

Notes

Oseltamivir

recommended for ages 2 years and older may cause nausea and vomiting

Zanamivir

for ages 7 and older risk of bronchospasm

Peramivir

approved for ages 2 and older may cause diarrhea

Baloxavir

for ages 12 and older

Multi-Drug Resistant Organisms

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial infection caused by a strain of Staphylococcus (“staph”) that is resistant to many of the antibiotics normally used to treat staph infections, including the beta-lactate agents ampicillin, amoxicillin, methicillin, penicillin, and cephalosporin.

Diagnosis: red area on the skin; swelling; pain; warm to the touch; pus or drainage from bumps on skin; fever; positive culture of MRSA bacterium
Management: antibiotics (trimethoprim, sulfamethoxazole, clindamycin linezolid)

Vancomycin-resistant enterococci (VRE) is a bacterial infection caused by strains of enterococci bacteria that are resistant to vancomycin.

  • Diagnosis: s/s of wound infection, pneumonia, UTI, meningitis, or sepsis; culture and sensitivity
  • Management (general): antibiotics (amoxicillin, ampicillin, gentamicin, penicillin, piperacillin, streptomycin)
  • Management (skin infections): daptomycin, linezolid, tedizolid, tigecycline
  • Management (intra-abdominal infections): piperacillin-tazobactam, imipenem, meropenem

Tuberculosis

Pathophysiology

Tuberculosis (TB) is a chronic, progressive bacterial infection of the lungs. There is an initial asymptomatic infection followed by a period of latency that may develop into active disease. Active TB produces granulomatous necrosis, more commonly known as lesions. The rupturing of the lesions in the pleural space can cause empyema, bronchopleural fistulas, or a pneumothorax.

Transmission and Precautions    

  • Person to person through respiratory droplets
  • Airborne precautions

Physical Examination

  1. Prolonged productive cough
  2. Fever and fatigue
  3. Night sweats
  4. Hemoptysis
  5. Dyspnea    

Diagnostic Tests

  • TB skin test (Mantoux skin test)
  • CXR showing multinodular infiltrate near the clavicle

Management

  • Supportive treatment for symptoms
  • 2 months of treatment with: isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), ethambutol (EMB)
  • After 2 months of treatment, PZA and EMB discontinued after 2 months; INH and RIF continue for another 4-7 months

Hemorrhagic Fevers

Pathophysiology

Viral hemorrhagic fevers (VHFs) are caused by several distinct groups of RNA viruses with the potential to cause severe, emergent disease. Hemorrhagic fevers are rare in the US and are usually diagnosed in travelers returning from areas where the viruses are endemic. Symptoms will develop within 1 to 3 weeks of exposure.

Virus

Endemic in

Crimean-Congo Hemorrhagic Fever (CCHF)

sub-Saharan Africa, the Middle East, Eastern Europe, Central Asia, and the Balkans

Dengue Fever

Central and South America, India, and Southeast Asia

Ebola

sub-Saharan Africa

Lassa

West Africa

Marburg

sub-Saharan Africa

Yellow Fever

tropical areas of Africa and South America

Transmission and Precautions 

  • Person-to-person transmission through contact with bodily fluids or mucous membranes
  • Patients with suspected VHF infection should be isolated
  • PPE: gown, mask, face shield, and gloves required

Physical Examination    

Most common presentation

  • High fever
  • Myalgia
  • Abdominal pain
  • Vomiting or diarrhea
  • Bleeding or hemorrhage

Hantavirus pulmonary syndrome (HPS): abrupt-onset VHF symptoms followed by respiratory distress

Hemorrhagic fever with renal syndrome (HFRS) 

  • Early symptoms include facial flushing, eye irritation and redness and petechiae rash
  • Late symptoms are hypovolemic shock and acute kidney failure that causes extreme fluid overload

Management

  • Treatment for VHFs is supportive (e.g., antipyretics, fluid replacement)
  • No antiviral treatment is available for most VHFs

Read More:

 

Book an appointment